BrainParrot

Union Health Ministry Observes World Antimicrobial Resistance Awareness Week 2026, Calls for Collective Action against AMR

GS2Full notePublished: · Updated:

Source: PIB (Press Information Bureau) · Read the original ↗

Summary

The Union Health Ministry inaugurated the national observance of World AMR Awareness Week 2026 at Kartavya Bhawan, New Delhi. The theme was "One Health, One Action: Prevent AMR Now". Health Secretary Punya Salila Srivastava called AMR one of the most serious public health challenges. She urged coordinated action across human, animal, plant, food and environmental sectors, and rational use of antibiotics by doctors, pharmacists and the public.

UPSC relevance: GS2 — Health; GS3 — S&T/Biotech (AMR), Environment (One Health)

Key facts for Prelims

  • World AMR Awareness Week: 18–24 November every year; 2026 theme "One Health, One Action: Prevent AMR Now".
  • NAP-AMR 2.0 (2025–29): launched by Union Health Minister J.P. Nadda in November 2025, during World AMR Awareness Week; first NAP-AMR was launched in 2017.
  • National Programme on AMR Containment: Health Ministry, coordinated by the National Centre for Disease Control (NCDC). Focus: lab capacity for AMR surveillance, infection prevention and control, antimicrobial stewardship and awareness.
  • One Health: links human, animal, plant/food systems and the environment.
  • Event participants: NHSRC, CDSCO, Department of Animal Husbandry, Indian Medical Association, All India Association of Druggists and Chemists.
  • Antibiotics are not effective against viral infections such as the common cold and influenza.
  • Union Health Secretary: Punya Salila Srivastava; Union Health Minister: J.P. Nadda.

Data and details

  • More than half of antimicrobial sales in India occur without prescriptions.
  • Nearly half of outpatient antibiotic prescriptions are inappropriate.
  • NAP-AMR 2.0 period: 2025–2029 (five years).
  • Measures participants identified to scale up:
  • public awareness campaigns;
  • preventing self-prescription;
  • proper disposal of antibiotics and expired medicines;
  • displaying legal warnings at drug shops against sale without prescription;
  • curbing substandard and spurious medicines;
  • appropriate antibiotic use in veterinary medicine, especially for food-producing animals;
  • quality standards in healthcare facilities to prevent infections.
  • Advice to the public:
  • no self-medication;
  • no sharing antibiotics;
  • no use of leftover medicines;
  • hygiene and sanitation, safe water, safe food and vaccination to reduce infections.
  • Roles stressed:
  • clinicians: prescribe only when clinically indicated, per treatment guidelines;
  • pharmacists: dispense only against valid prescriptions and counsel patients;
  • States/UTs, healthcare and educational institutions, and community organisations: carry the message to every section of society.
  • The Secretary said the commitment must extend beyond the awareness week and be seen in everyday prescribing, dispensing and use.
  • The release does not give AMR mortality or burden figures for India.

Static–dynamic linkage

AMR occurs when microbes (bacteria, viruses, fungi, parasites) evolve to resist drugs meant to kill them. Misuse and overuse of antimicrobials in humans, livestock, agriculture and the environment speeds this up. Because the drivers cross sectors, the policy response is the One Health approach, which recognises the interconnection of human, animal and environmental health. India's response is the National Action Plan on AMR, implemented through the Health Ministry's National Programme on AMR Containment, coordinated by the National Centre for Disease Control (NCDC).

Syllabus mapping: GS2 – Social Justice: health, government policies and interventions; GS3 – S&T: biotechnology and health; GS3 – Environment: pollution and ecosystem linkages; Prelims – Current events (health).

Background primer

Antimicrobial Resistance (AMR)

What it is:
Microorganisms such as bacteria, viruses, fungi and parasites evolve mechanisms to resist the drugs designed to kill them.

National Action Plan on AMR (NAP-AMR)

What it is:
India's multi-sector strategy to contain AMR under the One Health approach, coordinated by the Ministry of Health and Family Welfare.
Founded:
The first plan was developed in line with WHO's Global Action Plan on AMR and launched in 2017. The second version (2025–29) was launched by Health Minister J.P. Nadda. It was released on the first day of WHO's World AMR Awareness Week (18–24 November).
Members:
Development began in 2022 through stakeholder consultations across human health, research, professional, civil society, environment and animal husbandry sectors, followed by high-level meetings at NITI Aayog with more than 20 ministries and departments, each of which developed its own action plan with defined goals and timelines. The updated plan includes timelines and budgets for each key stakeholder to help monitor progress.
Mandate:
Raise awareness, strengthen laboratory capacity, enhance infection prevention, promote responsible prescribing, and develop medical countermeasures such as diagnostics, preventive tools and novel therapies.
Why it matters:
Nadda said version 2.0 addresses gaps in the first plan by increasing ownership of AMR efforts, strengthening inter-sectoral coordination and engaging the private sector more.

World AMR Awareness Week (WAAW)

Additional context

  • The Principal Scientific Adviser noted at the NAP-AMR 2.0 launch that Kerala and Gujarat were the first states to ban over-the-counter sales of antibiotics. This is relevant because the present release identifies sale without prescription as a major problem.
  • The India AMR Innovation Hub was set up with national and international stakeholders to build a novel technology platform.
  • Under India's G20 Presidency in 2023, AMR was highlighted in the Leaders' Declaration.
  • NAP-AMR 2.0 is described as expanding detection networks, genomic surveillance and environmental sampling for antibiotic residues, including monitoring of wastewater from hospitals, livestock farms and pharmaceutical facilities.
  • Critique: A Hindu editorial summarised by Vision IAS notes that implementation of the first plan was weak at State level, and that the new plan lacks mechanisms ensuring States develop plans, or joint review and statutory compliance requirements.
  • Global burden (per Vision IAS): around 4.95 million deaths a year are associated with AMR, of which 1.27 million are directly attributed to it.

Mains dimensions

  • Behavioural and regulatory drivers: Over-the-counter sales (more than half of sales without prescriptions) and inappropriate prescribing (nearly half of outpatient prescriptions) show that enforcement and prescriber behaviour matter as much as new drugs. The measures include legal warnings at drug shops and checks on substandard and spurious medicines, which tie into regulation through CDSCO and State drug controllers.
  • One Health in practice: The release names veterinary use in food-producing animals, plant and food systems and the environment, and Animal Husbandry officials attended. Making this operational needs coordination between ministries (Health, Animal Husbandry, Agriculture, Environment). NAP-AMR 2.0 attempts this through ministry-wise plans with timelines and budgets.
  • Federalism: Health is a State subject, and major determinants of AMR fall under State jurisdiction. States attended virtually. The critique that the NAP lacks mechanisms to compel State plans is relevant.
  • Public awareness and equity: Awareness drives need to reach those with limited access to qualified doctors, who often self-medicate or buy over the counter. Vaccination, sanitation and safe water reduce the need for antibiotics, linking AMR to public health infrastructure.
  • Innovation and the pipeline: Developing diagnostics and novel therapies is part of NAP-AMR 2.0. This links to India's biotech R&D and the AMR Innovation Hub.
  • Global leadership: India's role (G20 2023 declaration, the national plan aligned with WHO's Global Action Plan) positions it as a leader in AMR governance, but domestic implementation will decide credibility.

Possible Mains question

**GS2 / GS3, 15 marks:** "Antimicrobial resistance is a One Health challenge. Discuss India's policy response through the National Action Plan on AMR 2.0 and the challenges in implementing it across sectors and States."

Related topics

  • Drugs and Cosmetics Act, 1940; CDSCO; schedule-based restrictions on prescription drugs
  • WHO Global Action Plan on AMR; Quadripartite (WHO, FAO, WOAH, UNEP) One Health collaboration
  • National Centre for Disease Control, Integrated Disease Surveillance Programme
  • National Health Mission, health as a State subject (Seventh Schedule)
  • Veterinary antibiotic use, antibiotic residues in food and wastewater

Topics: GS2

How we write and check these notes →

All current affairs of 18 November 2026 → · UPSC Current Affairs